South Korean auto, pharma stocks fall after Trump threatens to impose 25% tariffs

Core Viewpoint - South Korean automaker and pharmaceutical stocks are experiencing declines following President Donald Trump's threat to increase tariffs on certain Korean imports to 25% due to government actions in South Korea [1] Group 1: Impact on Automakers - The threat of increased tariffs could significantly affect South Korean automakers, potentially leading to higher costs and reduced competitiveness in the U.S. market [1] - Investors are reacting negatively to the uncertainty surrounding trade relations, which may lead to a decrease in stock prices for major South Korean automotive companies [1] Group 2: Impact on Pharmaceutical Stocks - South Korean pharmaceutical stocks are also falling, reflecting concerns over potential trade barriers and their impact on the industry’s growth prospects [1] - The pharmaceutical sector may face challenges in exporting products to the U.S. if tariffs are implemented, which could hinder revenue growth [1]